Clinical Trial

Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma

Study acronym: FMT-LUMINATE
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to assess the anti-tumor activity of FMT administered in combination with ICI therapy.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2021-07-06; most recent amendment 2024-08-05.
Status change: Recruiting → Active, Not Recruiting 2024-02-19
Status change: Not Yet Recruiting → Recruiting 2021-12-09
Trial Details
NCT Number NCT04951583
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Non Small Cell Lung Cancer Metastatic, Advanced Melanoma
Enrollment 45 participants
Start Date 2021-11-16
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-07